What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Schizophrenia
- Psychiatry
Ariel Graff-Guerrero mainly focuses on Schizophrenia, Internal medicine, Psychiatry, Antipsychotic and Neuroscience.
His work in Schizophrenia addresses issues such as Cognition, which are connected to fields such as Clinical psychology.
His biological study spans a wide range of topics, including Endocrinology and Psychosis.
His research investigates the connection between Endocrinology and topics such as Agonist that intersect with problems in Radioligand and Globus pallidus.
Particularly relevant to Risperidone is his body of work in Psychiatry.
His studies in Antipsychotic integrate themes in fields like Positron emission tomography, Brief Psychiatric Rating Scale and Positive and Negative Syndrome Scale.
His most cited work include:
- Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology (301 citations)
- Higher Levels of Glutamate in the Associative-Striatum of Subjects with Prodromal Symptoms of Schizophrenia and Patients with First-Episode Psychosis (181 citations)
- Incentive motivation deficits in schizophrenia reflect effort computation impairments during cost-benefit decision-making (139 citations)
What are the main themes of his work throughout his whole career to date?
Schizophrenia, Internal medicine, Psychiatry, Antipsychotic and Neuroscience are his primary areas of study.
His Schizophrenia research is multidisciplinary, incorporating elements of Positron emission tomography, Psychosis and Cognition.
His Internal medicine research includes themes of Endocrinology and Oncology.
His Endocrinology study combines topics from a wide range of disciplines, such as Agonist and Glutamate receptor.
His Psychiatry study typically links adjacent topics like Clinical psychology.
His research integrates issues of Risperidone, Schizoaffective disorder and Brief Psychiatric Rating Scale in his study of Antipsychotic.
He most often published in these fields:
- Schizophrenia (51.25%)
- Internal medicine (47.19%)
- Psychiatry (34.69%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (47.19%)
- Schizophrenia (51.25%)
- In patient (7.50%)
In recent papers he was focusing on the following fields of study:
Ariel Graff-Guerrero focuses on Internal medicine, Schizophrenia, In patient, Antipsychotic and Dopamine.
The study incorporates disciplines such as Endocrinology and Cardiology in addition to Internal medicine.
His Schizophrenia research incorporates themes from Anterior cingulate cortex, Glutamatergic and Severity of illness.
The various areas that Ariel Graff-Guerrero examines in his Antipsychotic study include Glutamate receptor, Psychosis and Psychopathology, Clinical psychology.
His Dopamine research entails a greater understanding of Neuroscience.
He combines subjects such as Positron emission tomography and Emission computed tomography with his study of Dopamine receptor D2.
Between 2019 and 2021, his most popular works were:
- Brain insulin action in schizophrenia: Something borrowed and something new (11 citations)
- White matter microstructural organizations in patients with severe treatment-resistant schizophrenia: A diffusion tensor imaging study. (10 citations)
- Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy study. (10 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Schizophrenia
- Psychiatry
His main research concerns Schizophrenia, Internal medicine, Antipsychotic, In patient and Positive and Negative Syndrome Scale.
The concepts of his Schizophrenia study are interwoven with issues in Glutamatergic, Receptor, Dopamine receptor D2, Anterior cingulate cortex and Neuroscience.
His work in Neuroscience addresses subjects such as Insulin resistance, which are connected to disciplines such as Cognition.
His Internal medicine research is multidisciplinary, relying on both Positron emission tomography, Neuroimaging and Cardiology.
His studies deal with areas such as Psychological intervention, Clozapine, Psychosis, Clinical psychology and Craving as well as Antipsychotic.
His Positive and Negative Syndrome Scale study deals with the bigger picture of Psychiatry.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
